Highlights Only peptide company exhibiting at BEYOND 2026, Dave Asprey’s flagship biohacking, longevity, and consciousness conference Three immersive days in Austin, Texas — May 27-29, 2026 5,000+ attendees, 100+ speakers, 150+ exhibiting partners, and 30 experiential “hacktivations” Dedicated booth showcasing the Company’s peptide product line, including the needle-free BPC-157 transdermal patch Event comes ahead of the previously announced feature of CSO Justin Kirkland on The Human Upgrade with Dave Asprey, airing in June 2026 Vancouver, British Columbia–(Newsfile Corp. – May 28, 2026) – The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the “Company” or “BPC”), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces its participation in BEYOND, the biohacking, longevity, and consciousness conference founded and led by Dave Asprey, taking place May 27-29, 2026 in Austin, Texas. The Company will be the only peptide company exhibiting on the show floor and will operate a dedicated booth showcasing its peptide product line, including the needle-free BPC-157 transdermal patch.
This excerpt is quoted from the original release. Read the full announcement on Newsfile Corp.
Brief Summary
The Precision Peptide Company will be the only peptide company exhibiting at the prestigious BEYOND 2026 conference, led by biohacking pioneer Dave Asprey, from May 27-29, 2026, in Austin, Texas. The event will feature:
- 5,000+ attendees from the wellness and biohacking communities
- 100+ speakers discussing innovations in longevity and health
- 150+ exhibiting partners showcasing cutting-edge technologies
Visitors can explore the Company’s dedicated booth to learn more about their innovative peptide formulations, particularly the needle-free BPC-157 transdermal patch. This exhibition is timely, as it precedes the feature of CSO Justin Kirkland on The Human Upgrade with Dave Asprey which airs in June 2026. Why it matters: This participation underscores The Precision Peptide Company’s commitment to enhancing health and wellness through innovative peptide solutions.
Read the Full Article
This is a summary of the press release. For the complete article and any additional details, please visit the original source.
Attribution: Original press release by Newsfile Corp on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.